Report of Foreign Issuer (6-k)
13 December 2014 - 9:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington D.C.
20549
Form 6-K
REPORT OF FOREIGN
ISSUER
PURSUANT TO RULE
13a-16 OR 15d-16 OF
THE SECURITIES
EXCHANGE ACT OF 1934
For the month of
December 2014
Commission File
Number: 001-33036
Mindray Medical
International Limited
Mindray Building,
Keji 12th Road South,
Hi-tech Industrial
Park, Nanshan,
Shenzhen 518057
Peoples Republic
of China
(Address of principal
executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F x Form
40-F ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Indicate by check mark whether by furnishing
the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to
Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If Yes is marked, indicate
below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A
Mindray Medical International Limited (“Mindray”)
today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 10,
2014
At the meeting, Mindray shareholders voted to re-elect
incumbent directors Li Xiting and Kern Lim, each to serve a three-year term. Mindray’s shareholders did not re-elect
Peter Wan as a director.
In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the Company’s
independent registered public accounting firm for the fiscal year ending December 31, 2014.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Mindray Medical International Limited |
|
|
|
|
|
By: |
/s/ Alex Lung |
|
|
Name: |
Alex Lung |
|
|
Title: |
Chief Financial Officer |
|
Date: December 12, 2014
Montage Resources (NYSE:MR)
Historical Stock Chart
From Apr 2024 to May 2024
Montage Resources (NYSE:MR)
Historical Stock Chart
From May 2023 to May 2024